Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

654 results

Filters applied: . Clear all
Page 1
Clinical Outcomes in Elderly Patients with Chronic Subdural Hematoma: Validation of Irrigation Assignment Based on Hematoma Characteristics.
Maeda T, Kikkawa Y, Ehara T, Tsuchiya R, Tabata S, Onodera K, Kimura T, Take Y, Suzuki K, Kurita H. Maeda T, et al. Among authors: kimura t. Life (Basel). 2024 Apr 17;14(4):518. doi: 10.3390/life14040518. Life (Basel). 2024. PMID: 38672788 Free PMC article.
In conclusion, although the clinical outcomes of elderly patients were comparable to those of younger patients, the higher rate of preoperative antithrombotic therapy in elderly patients may result in a higher rate of recurrence requiring a long-term follow-up....
In conclusion, although the clinical outcomes of elderly patients were comparable to those of younger patients, the higher rate of preoperat …
Subclinical myocardial damage after anthracycline chemotherapy in Japanese patients with breast cancer.
Nakatsuma K, Ozasa N, Ohno M, Ishiguro H, Minami M, Nishi E, Toi M, Ono K, Kimura T. Nakatsuma K, et al. Among authors: kimura t. J Cardiol. 2024 Mar 22:S0914-5087(24)00044-3. doi: 10.1016/j.jjcc.2024.03.005. Online ahead of print. J Cardiol. 2024. PMID: 38521118
Although, these patients were diagnosed with mild asymptomatic CTRCD, careful long-term follow-up will be required....
Although, these patients were diagnosed with mild asymptomatic CTRCD, careful long-term follow-up will be required....
Prognostic value of E/e' ratio and its change over time in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction in the reperfusion era.
Miyake M, Izumi C, Watanabe H, Ozasa N, Morimoto T, Matsutani H, Takahashi S, Ohtani Y, Baba M, Sakamoto J, Tamaki Y, Enomoto S, Kondo H, Tamura T, Nakagawa Y, Kimura T; CAPITAL-RCT Investigators. Miyake M, et al. Among authors: kimura t. J Cardiol. 2024 Mar 14:S0914-5087(24)00041-8. doi: 10.1016/j.jjcc.2024.03.002. Online ahead of print. J Cardiol. 2024. PMID: 38490639
BACKGROUND: The ratio of early diastolic mitral inflow velocity to mitral annular velocity (E/e') is a prognostic factor in patients with ST-segment elevation myocardial infarction (STEMI). However, data are lacking on long-term outcomes and longitudinal changes in E/e' in …
BACKGROUND: The ratio of early diastolic mitral inflow velocity to mitral annular velocity (E/e') is a prognostic factor in patients with ST …
Cobalt protoporphyrin promotes heme oxygenase 1 expression and ameliorates cardiac dysfunction in long-term fasting mice.
Shiba M, Kato T, Seko Y, Minamino-Muta E, Tanada Y, Kimura T, Ono K. Shiba M, et al. Among authors: kimura t. Int J Cardiol. 2024 Jun 1;404:131972. doi: 10.1016/j.ijcard.2024.131972. Epub 2024 Mar 14. Int J Cardiol. 2024. PMID: 38490272
We hypothesized that the administration of HO-1 inducer, cobalt protoporphyrin (CoPP) reduces oxidative stress and ameliorates cardiac systolic dysfunction in long-term fasting mice. METHODS: C57BL/6 J mice were classified into three groups: fed mice (fed group), 48-h fast …
We hypothesized that the administration of HO-1 inducer, cobalt protoporphyrin (CoPP) reduces oxidative stress and ameliorates cardiac systo …
The Absorb GT1 Bioresorbable Vascular Scaffold System　- 5-Year Post-Market Surveillance Study in Japan.
Nakamura M, Suzuki N, Fujii K, Furuya J, Kawasaki T, Kimura T, Sakamoto T, Tanabe K, Kusano H, Stockelman KA, Kozuma K. Nakamura M, et al. Among authors: kimura t. Circ J. 2024 Mar 13. doi: 10.1253/circj.CJ-23-0877. Online ahead of print. Circ J. 2024. PMID: 38479861 Free article.
BACKGROUND: The 1-year clinical outcomes of the Absorb GT1 Japan post-market surveillance (PMS) suggested that an appropriate intracoronary imaging-guided bioresorbable vascular scaffold (BVS) implantation technique may reduce the risk of target lesion failure (TLF) and scaffold …
BACKGROUND: The 1-year clinical outcomes of the Absorb GT1 Japan post-market surveillance (PMS) suggested that an appropriate intracoronary …
Surgery for pulmonary lesions in patients with a history of urinary tract transitional cell carcinoma.
Kanzaki R, Nagoya A, Taniguchi S, Ishida H, Kimura K, Fukui E, Kimura T, Kanou T, Ose N, Funaki S, Minami M, Morii E, Shintani Y. Kanzaki R, et al. Among authors: kimura t. J Cardiothorac Surg. 2024 Mar 12;19(1):117. doi: 10.1186/s13019-024-02607-z. J Cardiothorac Surg. 2024. PMID: 38475921 Free PMC article.
METHODS: In the present study, the data of 37 consecutive patients with a history of TCC who underwent pulmonary resection for solitary pulmonary lesions were reviewed, and the clinical factors and short- and long-term outcomes were analyzed. RESULTS: The study population …
METHODS: In the present study, the data of 37 consecutive patients with a history of TCC who underwent pulmonary resection for solitary pulm …
Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2.
Ogihara Y, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Sato T, Nishikawa R, Kimura T, Dohi K; COMMAND VTE Registry-2 Investigators. Ogihara Y, et al. Among authors: kimura t. Thromb Res. 2024 Apr;236:191-200. doi: 10.1016/j.thromres.2024.02.023. Epub 2024 Feb 29. Thromb Res. 2024. PMID: 38461613
Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy.
Yamazaki M, Kawano H, Miyoshi M, Kimura T, Takahashi K, Muto S, Horie S. Yamazaki M, et al. Among authors: kimura t. Int J Mol Sci. 2024 Feb 8;25(4):2088. doi: 10.3390/ijms25042088. Int J Mol Sci. 2024. PMID: 38396765 Free PMC article.
Data for predictive factors indicating patients more likely to benefit from long-term tolvaptan are lacking. Data were retrospectively collected from 55 patients on tolvaptan for 6 years. ...Family history of ADPKD and baseline BMI were contributing factors for deltaeGFR/y …
Data for predictive factors indicating patients more likely to benefit from long-term tolvaptan are lacking. Data were retrospectivel …
654 results